Appraisal in progress
Indication |
|
| Status: In progress | |
Adjunctive therapy to preparations of levodopa/ DOPA decarboxylase inhibitors (DDCI) in adult patients with Parkinson's disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations. |
|
Medicine details |
|
| Medicine name | opicapone (Ongentys®) |
| Formulation | 50 mg hard capsule |
| Reference number | 5285 |
| Indication | As above |
| Company | Bial – Portela & Cª, S.A |
| BNF chapter | Central nervous system |
| Submission type | Limited |
| Status | In progress |
| NMG meeting date | 10/04/2024 |
| AWMSG meeting date | 14/05/2024 |
| Date of issue | TBC |